1. Cavinton
2. Ethyl Apovincaminate
3. Ethyl Apovincaminate Tartrate (1:1)
4. Ethyl Apovincaminate, (+-)-isomer
5. Ethyl Apovincaminate, (16alpha)-isomer
6. Ethyl Apovincaminate, (3alpha,16alpha)-isomer
7. Ethyl Apovincaminate, 2-oxopentanedioate (1:1)
8. Ethyl Apovincaminate, 3h-labeled
9. Kavinton
10. Rgh-4405
11. Tcv-3b
1. 42971-09-5
2. Cavinton
3. Ceractin
4. Apovincaminic Acid Ethyl Ester
5. Bravinton
6. Ethyl Apovincamin-22-oate
7. Ultra-vinca
8. Tcv-3b
9. Rgh 4405
10. Ethyl (+)-apovincaminate
11. Vinporal
12. Cis-apovincaminic Acid Ethyl Ester
13. Rgh-4405
14. Ethyl (+)-cis-apovincaminate
15. Tcv 3b
16. (+)-apovincaminic Acid Ethyl Ester
17. Ethyl Apovincaminate
18. (+)-cis-apovincaminic Acid Ethyl Ester
19. Ay 27,255
20. 3-alpha,16-alpha-apovincaminic Acid Ethyl Ester
21. Nsc-760093
22. Chembl71752
23. Ay-27,255
24. Mls000069635
25. 543512obtc
26. (41s,13as)-ethyl 13a-ethyl-2,3,41,5,6,13a-hexahydro-1h-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
27. Ncgc00018204-09
28. Vinpocetinum
29. Ay-27255
30. Smr000058241
31. Eburnamenine-14-carboxylic Acid, Ethyl Ester, (3alpha,16alpha)-
32. Dsstox_cid_3740
33. Dsstox_rid_77176
34. Dsstox_gsid_23740
35. Ethyl (41s,13as)-13a-ethyl-2,3,41,5,6,13a-hexahydro-1h-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
36. Vinpocetinum [inn-latin]
37. Eburnamenine-14-carboxylic Acid, Ethyl Ester, (3a,16a)-
38. Apovincaminate D'ethyle
39. Apovincaminate D'ethyle [french]
40. Ethyl (15s,19s)-15-ethyl-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate
41. Eburnamenine-14-carboxylic Acid Ethyl Ester
42. Sr-01000075633
43. Einecs 256-028-0
44. Brn 0900803
45. Vinpocetin
46. Unii-543512obtc
47. Vinpocetine (jan/usan/inn)
48. Vinpocetine-ethyl Apovincaminate
49. 3a,16a-apovincaminic Acid Ethyl Ester
50. Ncgc00016854-03
51. Vinpocetine [usan:inn:ban:jan]
52. Prestwick_963
53. Vinpocetin- Bio-x
54. Cas-42971-09-5
55. Mfcd00211233
56. Spectrum_001400
57. Vinpocetine (cavinton)
58. Ay 27255
59. Specplus_000327
60. Vinpocetine [mi]
61. Opera_id_1325
62. Prestwick0_000268
63. Prestwick1_000268
64. Prestwick2_000268
65. Prestwick3_000268
66. Spectrum2_001529
67. Spectrum3_000961
68. Spectrum4_001075
69. Spectrum5_000966
70. Vinpocetine [dsc]
71. Vinpocetine [inn]
72. Vinpocetine [jan]
73. Vinpocetine [usan]
74. V 6383
75. Vinpocetine [vandf]
76. Vinpocetine [mart.]
77. Lopac0_001257
78. Schembl50081
79. Bspbio_000116
80. Bspbio_002561
81. Kbiogr_001430
82. Kbioss_001880
83. Vinpocetine [usp-rs]
84. Vinpocetine [who-dd]
85. Mls001076294
86. Divk1c_006423
87. Spectrum1503115
88. Vinpocetine, >=98%, Solid
89. Ethyl (3alpha,16alpha)-eburnamenine-14-carboxylate
90. Spbio_001318
91. Spbio_002335
92. Bpbio1_000128
93. Cid_443955
94. Gtpl5285
95. Vinpocetine, Analytical Standard
96. Dtxsid5023740
97. Regid_for_cid_443955
98. Chebi:32297
99. Kbio1_001367
100. Kbio2_001880
101. Kbio2_004448
102. Kbio2_007016
103. Kbio3_001781
104. Hms1568f18
105. Hms1922g05
106. Hms2090j22
107. Hms2092l06
108. Hms2095f18
109. Hms3263l16
110. Hms3402d12
111. Hms3411h11
112. Hms3675h11
113. Hms3712f18
114. Hms3887e17
115. Pharmakon1600-01503115
116. Vinpocetine [ep Monograph]
117. (3alpha, 16alpha)-eburnamenine-14-carboxylic Acid Ethyl Ester
118. 68780-77-8
119. Amy39087
120. Bcp04123
121. Tox21_110648
122. Tox21_110839
123. Tox21_501257
124. Bdbm50059033
125. Ccg-39307
126. Eburnamenine-14-carboxylic Acid, Ethyl Ester, (3-alpha,16-alpha)-
127. Nsc760093
128. Pd-185
129. S2110
130. Zinc19796031
131. Akos015896480
132. Tox21_110648_1
133. Cs-0545
134. Db12131
135. Lp01257
136. Nsc 760093
137. Sdccgsbi-0051224.p003
138. Vinpocetine 1.0 Mg/ml In Acetonitrile
139. (3s,16s)-apovincaminic Acid Ethylester
140. Ncgc00018204-05
141. Ncgc00018204-06
142. Ncgc00018204-07
143. Ncgc00018204-08
144. Ncgc00018204-10
145. Ncgc00018204-11
146. Ncgc00018204-13
147. Ncgc00021727-04
148. Ncgc00021727-05
149. Ncgc00021727-06
150. Ncgc00021727-07
151. Ncgc00168782-01
152. Ncgc00261942-01
153. Ncgc00263865-01
154. Ncgc00263865-04
155. Ac-22612
156. As-13868
157. Bv164528
158. Hy-13295
159. Eburnamenine-14-carboxylic Acid Ethyl Ester;
160. Eu-0101257
161. V0115
162. D01371
163. Ab00052317_02
164. 971v095
165. Q420288
166. Sr-01000000118
167. Sr-01000000118-3
168. Sr-01000075633-1
169. Sr-01000075633-3
170. Sr-01000075633-4
171. W-202748
172. Brd-k53318339-001-05-8
173. (3?,16?)-eburnamenine-14-carboxylic Acid Ethyl Ester
174. Vinpocetine, European Pharmacopoeia (ep) Reference Standard
175. Vinpocetine, United States Pharmacopeia (usp) Reference Standard
176. Eburnamenine 14-carboxylic Acid Ethyl Ester (3.alpha.,16.alpha.)
177. (11as,11bs)-11a-ethyl-2,3,4,5,11a,11b-hexahydro-1h-3a,9b-diaza-benzo[cd]fluoranthene-10-carboxylic Acid Ethyl Ester
178. (3as,11bs)-3a-ethyl-1,2,3,3a,10,11b-hexahydro-11h-5a,11a-diaza-benzo[cd]fluoranthene-5-carboxylic Acid Ethyl Ester
179. (41s,13as)-ethyl13a-ethyl-2,3,41,5,6,13a-hexahydro-1h-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate
180. 115986-87-3
181. 11a-ethyl-2,3,4,5,11a,11b-hexahydro-1h-3a,9b-diaza-benzo[cd]fluoranthene-10-carboxylic Acid 2-nitrooxy-ethyl Ester(vinpocetine)
182. Ethyl (15s,19s)-15-ethyl-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2(7),3,5,8(18),16-pentaene-17-carboxylate
183. Ethyl (15s,19s)-15-ethyl-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2,4,6,8(18),16-pentaene-17-carboxylate
| Molecular Weight | 350.5 g/mol |
|---|---|
| Molecular Formula | C22H26N2O2 |
| XLogP3 | 4.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 350.199428076 g/mol |
| Monoisotopic Mass | 350.199428076 g/mol |
| Topological Polar Surface Area | 34.5 Ų |
| Heavy Atom Count | 26 |
| Formal Charge | 0 |
| Complexity | 617 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Neuroprotective Agents
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)
Phosphodiesterase Inhibitors
Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Nootropic Agents
Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)
N - Nervous system
N06 - Psychoanaleptics
N06B - Psychostimulants, agents used for adhd and nootropics
N06BX - Other psychostimulants and nootropics
N06BX18 - Vinpocetine
LOOKING FOR A SUPPLIER?
